The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.
about
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersTime and space profiling of NMDA receptor co-agonist functionsHistory of the Concept of Disconnectivity in Schizophrenia.Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patientsCo-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapsesHeterogeneity of D-Serine Distribution in the Human Central Nervous System.Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving miceNeuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus.Possible compensatory mechanisms for glutamatergic disconnection found in the auditory cortex in schizophreniaFunctional Uncoupling NMDAR NR2A Subunit from PSD-95 in the Prefrontal Cortex: Effects on Behavioral Dysfunction and Parvalbumin Loss after Early-Life StressThe Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.Computationally Discovered Potentiating Role of Glycans on NMDA Receptors.Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.Potential synergistic action of 19 schizophrenia risk genes in the thalamus.The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis.Novel PAMs Targeting NMDAR GluN2A Subunit.D-Amino Acids in the Nervous and Endocrine Systems.Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.NMDA receptors: linking physiological output to biophysical operation.Managing Negative Symptoms of Schizophrenia: How Far Have We Come?A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine/D-serine.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders.Genome-Wide Target Analyses of Otx2 Homeoprotein in Postnatal CortexAn evolutionary switch in ND2 enables Src kinase regulation of NMDA receptorsAn mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.Astrocytes in Primary Cultures Express Serine Racemase, Synthesize D-Serine and Acquire A1 Reactive Astrocyte Features.N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.Schizophrenia: Basic and Clinical.Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.CSF GABA is reduced in first-episode psychosis and associates to symptom severity.Glycine Transporters and Its Coupling with NMDA Receptors.Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood.In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.Astroglia, Glutamatergic Transmission and Psychiatric Diseases.A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.The Role of Serine Racemase in the Pathophysiology of Brain Disorders.An in Silico, Biomarker-Based Method for the Evaluation of Virtual Neuropsychiatric Drug Effects.
P2860
Q26769948-E32DB59A-CEE0-44B9-944F-2F05FBF90F56Q28084245-C362BB2B-DD25-497E-839F-9504545CB990Q31054567-029BD77A-CD91-4CC4-A540-C18BA21A79F6Q33718794-CFAD6085-DC20-4238-B43C-E1C784AF5C08Q33784099-EE5658D7-451C-4892-AF9A-7886DECEADD8Q33797251-D203046E-C724-4CAF-9918-14CE4F94135AQ36285068-852404C6-0770-4F0A-811F-419C62B4B4C0Q36722299-082C6056-993B-47B3-83B3-5DE74FD44956Q36724465-EB0142C8-4A99-450F-AA3C-723766540965Q36894599-A4D40DD1-30F8-40D5-B652-4213ED4D803AQ37490383-2370C0F5-640E-4951-AEBB-AD71613EC648Q37738255-46872107-E5B9-4ACB-A13A-15E5C4139C3AQ38669576-0FF495F2-0392-4A7C-9F89-4474969A9637Q38816381-C9FCD502-FD79-4839-ACBD-B1712EFBCDD0Q38914044-60A132C3-5509-428B-A65C-B5B12CBD45E9Q38958804-288B4A85-B6B7-4C19-90BF-906A53304B80Q38980990-EFB89ACA-09C2-4EF2-9AB4-CB9EB53EE02EQ39039972-9323DC8B-92B3-47B4-A1F4-B4083CECEB11Q39067787-0E07B1D3-4B66-49E5-A5CF-8C76C4FB1583Q39121207-5B8191BB-8175-4C68-A7EC-17C066126138Q39182931-A0FB6BC6-B8E0-41C8-8990-D558F512C7EBQ39233330-E28DEF39-A5F1-443F-93B4-0655026D1713Q41051708-DA2482C6-A826-4FD8-9E3B-00ABAE771035Q41666702-CF7AE929-381B-4EB9-B154-7BC8EDD00ED0Q41700939-9A5FFF6F-5D9A-40DD-89CC-AD4C204A95BCQ42236533-54F1BD86-5A9B-4004-8970-A1104CDC8149Q42250780-975CDF70-2289-4305-AB8A-1CF6884F6CD1Q42710424-12F50F85-36AF-4EA3-AEB2-02D8991BC6B1Q47228241-609897E4-B451-4C78-8BF6-2B2C431BCB92Q47305639-13BCA92D-69D3-4CE5-812D-720694751856Q47677836-DB62D210-74FD-480F-8257-A76C89C53E36Q47680320-140BB306-3562-4AF7-B0E6-333CD3A4C3EDQ47777392-2189A8EF-4CFA-40C6-8228-21189237F47BQ47791708-B8755326-C8D9-4D2F-905D-3476028361F1Q47973666-34709821-2F9B-4328-A3B2-3552C5F733D7Q48019214-08F4C27D-487B-4EEA-AB25-80C07CDB30BEQ48027529-266AA334-1916-46B5-BF8A-C540FC7A057CQ48137280-DF193CC5-C427-40A5-9C65-16BD85D12EECQ50138246-94A1ADA2-07CD-4653-BA0A-514175D932CAQ50309747-940A1B59-7CB3-400D-863C-7B9CD51EB26E
P2860
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@ast
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@en
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@nl
type
label
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@ast
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@en
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@nl
prefLabel
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@ast
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@en
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@nl
P2860
P1476
The NMDA receptor 'glycine mod ...... D-serine, glycine, and beyond.
@en
P2093
Darrick T Balu
Joseph T Coyle
P2860
P304
P356
10.1016/J.COPH.2014.12.004
P577
2014-12-23T00:00:00Z